- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 5.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.63M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 5.5M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.35M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.11M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.74M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $9.18M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.17M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.58M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.21M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.65M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.78M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $11.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.84M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $12.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.39 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.38 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.39 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.38 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $249K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $447K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.19M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.08M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.26M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$393K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $196K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $584K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $205K |
| Capex | Q1 2026 · Mar 31, 2025 | $4K |